Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Healthy Extracts (HYEX) EBITDA Margin (2016 - 2025)

Healthy Extracts' EBITDA Margin history spans 11 years, with the latest figure at 15.9% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 927.0% year-over-year to 15.9%; the TTM value through Dec 2025 reached 20.92%, down 1505.0%, while the annual FY2025 figure was 20.92%, 1504.0% down from the prior year.
  • EBITDA Margin reached 15.9% in Q4 2025 per HYEX's latest filing, up from 50.12% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 11.46% in Q3 2024 to a low of 344.47% in Q1 2021.
  • Average EBITDA Margin over 5 years is 64.67%, with a median of 33.84% recorded in 2024.
  • Peak YoY movement for EBITDA Margin: surged 113627bps in 2021, then tumbled -8269bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 86.39% in 2021, then soared by 72bps to 24.1% in 2022, then crashed by -100bps to 48.14% in 2023, then soared by 48bps to 25.17% in 2024, then surged by 37bps to 15.9% in 2025.
  • Per Business Quant, the three most recent readings for HYEX's EBITDA Margin are 15.9% (Q4 2025), 50.12% (Q3 2025), and 10.9% (Q2 2025).